Artículos -

Navegar

Últimos Documentos Autor FCEN - Año Autor FCEN - Revista Año - Revista Revista - Año SubjectPcEn Colores Type

Colección

Lista de

$
0
1
-
1
1
-
1
-
1
-
1
1
1
2
3
4
5
6
7
8
9
a
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
‐
a
-
‐
-
a
-
a
-
a
-
a
-
a
-
a
-
‐
a
-
a
-
a
-
a
b
-
b
-
b
-
b
c
-
c
-
c
-
c
-
c
-
c
-
c
-
c
-
c
+
c
-
c
-
c
-
c
-
c
-
c
-
c
-
c
c
-
c
-
c
d
-
d
-
d
-
d
-
d
-
d
-
d
e
-
e
-
e
-
e
-
e
-
e
-
e
-
e
-
e
f
-
f
-
f
f
g
-
g
-
g
-
g
-
g
-
g
-
g
-
g
-
‐
g
-
g
-
‐
g
-
g
h
‐
h
h
-
h
-
h
-
h
-
h
i
-
i
j
k
-
k
-
k
-
k
-
k
-
k
l
-
l
-
l
-
l
-
l
-
l
-
l
l
+
l
±
l
l
m
-
m
-
m
-
m
-
m
-
m
+
m
-
m
-
m
-
m
-
‐
m
n
-
n
-
n
-
n
-
n
o
p
-
p
p
-
p
-
p
q
r
-
r
-
r
s
-
s
-
s
{
s
-
s
t
-
t
‐
-
t
-
t
-
t
t
-
t
u
v
v
w
x
-
x
y
z
α
β
—
,
δ
π
-

tumor growth

"Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM/CD166), synergistically delays in vivo breast cancer growth" (2019) Ferragut, F.;Cagnoni, A.J.;Colombo, L.L. (...)Elola, M.T. Biochimica et Biophysica Acta - Molecular Cell Research

"Inhibition of Notch signaling attenuates pituitary adenoma growth in Nude mice" (2019) Zubeldía-Brenner, L.;De Winne, C.;Perrone, S. (...)Becu-Villalobos, D. Endocrine-Related Cancer. 26(1):13-29

"New insights in cushing disease treatment with focus on a derivative of vitamin A" (2018) Fuertes, M.;Tkatch, J.;Rosmino, J. (...)Arzt, E. Frontiers in Endocrinology. 9(MAY)

"Predictive outcomes for HER2-enriched cancer using growth and metastasis signatures driven by SPARC" (2017) Guttlein, L.N.;Benedetti, L.G.;Fresno, C. (...)Podhajcer, O.L. Molecular Cancer Research. 15(3):304-316

"Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways" (2016) Rabinovich, G.A.; Conejo-García, J.R. Journal of Molecular Biology. 428(16):3266-3281

"CtBP1 associates metabolic syndrome and breast carcinogenesis targeting multiple miRNAs" (2016) De Luca, P.;Dalton, G.N.;Scalise, G.D. (...)De Siervi, A. Oncotarget. 7(14):18798-18811

"Glyco-nano-oncology: Novel therapeutic opportunities by combining small and sweet" (2016) Hockl, P.F.;Wolosiuk, A.;Pérez-Sáez, J.M. (...)Rabinovich, G.A. Pharmacological Research. 109:45-54

"NK cells restrain spontaneous antitumor CD8+ T cell priming through pd-1/pd-l1 interactions with dendritic cells" (2016) Raffo Iraolagoitia, X.L.;Spallanzani, R.G.;Torres, N.I. (...)Fuertes, M.B. Journal of Immunology. 197(3):953-961

"The thyroid hormone triiodothyronine reinvigorates dendritic cells and potentiates anti-tumor immunity" (2016) Alamino, V.A.; Montesinos, M.M.; Rabinovich, G.A.; Pellizas, C.G. OncoImmunology. 5(1)

"RSUME is implicated in tumorigenesis and metastasis of pancreatic neuroendocrine tumors" (2016) Wu, Y.;Tedesco, L.;Lucia, K. (...)Stalla, G.K. Oncotarget. 7(36):57878-57893

"Thyroid hormones and their membrane receptors as therapeutic targets for T cell lymphomas" (2016) Cremaschi, G.A.;Cayrol, F.;Sterle, H.A. (...)Barreiro Arcos, M.L. Pharmacological Research. 109:55-63

"Classical and non-classical thyroid hormone intracellular pathways involved in T lymphoma growth" (2015) Arcos, M.L.B.;Sterle, H.;Cayrol, F. (...)Cremaschi, G.A. Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry. 15(1):37-42

"Low doses of CPS49 and flavopiridol combination as potential treatment for advanced prostate cancer" (2015) Zalazar, F.;De Luca, P.;Gardner, K. (...)De Siervi, A. Current Pharmaceutical Biotechnology. 16(6):553-563

"RSUME inhibits VHL and regulates its tumor suppressor function" (2015) Gerez, J.;Tedesco, L.;Bonfiglio, J.J. (...)Arzt, E. Oncogene. 34(37):4855-4866

"Human MageB2 protein expression enhances E2F transcriptional activity, cell proliferation, and resistance to ribotoxic stress" (2015) Peche, L.Y.;Ladelfa, M.F.;Toledo, M.F. (...)Monte, M. Journal of Biological Chemistry. 290(49):29652-29662

"Antitumor responses stimulated by dendritic cells are improved by triiodothyronine binding to the thyroid hormone receptor β" (2015) Alamino, V.A.;Mascanfroni, I.D.;Montesinos, M.M. (...)Pellizas, C.G. Cancer Research. 75(7):1265-1274

"Introduction to special issue: Glycans in vascular biology" (2014) Thijssen, V.L.; Rabinovich, G.A. Glycobiology. 24(12):1235-1236

"The rigid steroid 21-hydroxy-6,19-epoxyprogesterone (21OH-6,19OP) is a dissociated glucocorticoid receptor modulator potentially useful as a novel coadjuvant in breast cancer chemotherapy" (2014) Orqueda, A.J.;Dansey, M.V.;Español, A. (...)Pecci, A. Biochemical Pharmacology. 89(4):526-535

"Human adipose tissue from normal and tumoral breast regulates the behavior of mammary epithelial cells" (2013) Pistone Creydt, V.;Fletcher, S.J.;Giudice, J. (...)Calvo, J.C. Clinical and Translational Oncology. 15(2):124-131

"Mesenchymal stem cells and their use in therapy: What has been achieved?" (2013) Fernández Vallone, V.B.;Romaniuk, M.A.;Choi, H. (...)Chasseing, N.A. Differentiation. 85(1-2):1-10

"Expansion of CD11b+Ly6G+Ly6Cint cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions" (2013) Spallanzani, R.G.;Dalotto-Moreno, T.;Raffo Iraolagoitia, X.L. (...)Zwirner, N.W. Cancer Immunology, Immunotherapy. 62(12):1781-1795

"Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease" (2013) Dalotto-Moreno, T.;Croci, D.O.;Cerliani, J.P. (...)Salatino, M. Cancer Research. 73(3):1107-1117

"Inhibitor of growth 1 (ING1) acts at early steps of multiple DNA repair pathways" (2013) Ceruti, J.M.;Ogara, M.F.;Menéndez, C. (...)Cánepa, E.T. Molecular and Cellular Biochemistry. 378(1-2):117-126

"Antitumor activity of histamine and clozapine in a mouse experimental model of human melanoma" (2013) Massari, N.A.;Medina, V.A.;Cricco, G.P. (...)Rivera, E.S. Journal of Dermatological Science. 72(3):252-262

"Anti-tumor effect of SLPI on mammary but not colon tumor growth" (2013) Amiano, N.O.;Costa, M.J.;Reiteri, R.M. (...)Chuluyan, H.E. Journal of Cellular Physiology. 228(2):469-475

"Thrombospondin-1 (TSP-1) analogs ABT-510 and ABT-898 inhibit prolactinoma growth and recover active pituitary transforming growth factor-β1 (TGF-β1)" (2012) Recouvreux, M.V.;Camilletti, M.A.;Rifkin, D.B. (...)Díaz-Torga, G. Endocrinology. 153(8):3861-3871

"Advanced prostate cancer: Reinforcing the strings between inflammation and the metastatic behavior" (2012) Gueron, G.; De Siervi, A.; Vazquez, E. Prostate Cancer and Prostatic Diseases. 15(3):213-221

"Aquaporins: Another piece in the osmotic puzzle" (2012) Alleva, K.; Chara, O.; Amodeo, G. FEBS Letters. 586(19):2991-2999

"Mathematical modeling of human glioma growth based on brain topological structures: Study of two clinical cases" (2012) Suarez, C.;Maglietti, F.;Colonna, M. (...)Marshall, G. PLoS ONE. 7(6)

"Oral administration of fluoxetine alters the proliferation/apoptosis balance of lymphoma cells and up-regulates T cell immunity in tumor-bearing mice" (2011) Frick, L.R.;Rapanelli, M.;Arcos, M.L.B. (...)Genaro, A.M. European Journal of Pharmacology. 659(2-3):265-272

"Novel roles of galectin-1 in hepatocellular carcinoma cell adhesion, polarization, and in vivo tumor growth" (2011) Espelt, M.V.;Croci, D.O.;Bacigalupo, M.L. (...)Troncoso, M.F. Hepatology. 53(6):2097-2106

"Effect of SOM230 (Pasireotide) on corticotropic cells: Action in dogs with Cushing's disease" (2011) Castillo, V.;Theodoropoulou, M.;Stalla, J. (...)Arzt, E. Neuroendocrinology. 94(2):124-136

"When the optimal is not the best: Parameter estimation in complex biological models" (2010) Fernández Slezak, D.;Suárez, C.;Cecchi, G.A. (...)Stolovitzky, G. PLoS ONE. 5(10)

"Enhanced LH action in transgenic female mice expressing hCGβ-subunit induces pituitary prolactinomas; the role of high progesterone levels" (2010) Ahtiainen, P.;Sharp, V.;Rulli, S.B. (...)Huhtaniemi, I. Endocrine-Related Cancer. 17(3):611-621

"VEGF and CD31 association in pituitary adenomas" (2010) Cristina, C.;Perez-Millan, M.I.;Luque, G. (...)Becu-Villalobos, D. Endocrine Pathology. 21(3):154-160

"c-Jun regulates phosphoinositide-dependent kinase 1 transcription: Implication for Akt and protein kinase C activities melanoma tumorigenesis" (2010) Lopez-Bergami, P.;Kim, H.;Dewing, A. (...)Ronai, Z. Journal of Biological Chemistry. 285(2):903-913

"Tolerogenic dendritic cells in the control of autoimmune neuroinflammation: An emerging role of protein-glycan interactions" (2010) Ilarregui, J.M.; Rabinovich, G.A. NeuroImmunoModulation. 17(3):157-160

"Conveying glycan information into T-cell homeostatic programs: A challenging role for galectin-1 in inflammatory and tumor microenvironments" (2009) Rabinovich, G.A.; Ilarregui, J.M. Immunological Reviews. 230(1):144-159

"Invasive giant prolactinoma with loss of therapeutic response to cabergoline: Expression of angiogenic markers" (2009) Mallea-Gil, M.S.;Cristina, C.;Perez-Millan, M.I. (...)Becu-Villalobos, D. Endocrine Pathology. 20(1):35-40

"Identification of new Rel/NFκB regulatory networks by focused genome location analysis" (2009) De Siervi, A.;De Luca, P.;Moiola, C. (...)Gardner, K. Cell Cycle. 8(13):2093-2100

"Critical role of the solvent environment in galectin-1 binding to the disaccharide lactose" (2009) Di Lella, S.;Ma, L.;Díaz Ricci, J.C. (...)Álvarez, R.M.S. Biochemistry. 48(4):786-791

"Chronic restraint stress impairs T-cell immunity and promotes tumor progression in mice" (2009) Frick, L.R.;Barreiro Arcos, M.L.;Rapanelli, M. (...)Cremaschi, G.A. Stress. 12(2):134-143

"Reversal of antiprogestin resistance and progesterone receptor isoform ratio in acquired resistant mammary carcinomas" (2009) Wargon, V.;Helguero, L.A.;Bolado, J. (...)Lanari, C. Breast Cancer Research and Treatment. 116(3):449-460

"Reduced glioma growth following dexamethasone or anti-angiopoietin 2 treatment" (2008) Villeneuve, J.;Galarneau, H.;Beaudet, M.-J. (...)Vallières, L. Brain Pathology. 18(3):401-414

"MMTV-induced pregnancy-dependent mammary tumors: Early history and new perspectives" (2008) Kordon, E.C. Journal of Mammary Gland Biology and Neoplasia. 13(3):289-297

"Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer" (2008) Salatino, M.;Croci, D.O.;Bianco, G.A. (...)Rabinovich, G.A. Expert Opinion on Biological Therapy. 8(1):45-57

"Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft" (2007) Gazzaniga, S.;Bravo, A.I.;Guglielmotti, A. (...)Wainstok, R. Journal of Investigative Dermatology. 127(8):2031-2041

"The Gα12/13 family of heterotrimeric G proteins and the small GTPase RhoA link the Kaposi sarcoma-associated herpes virus G protein-coupled receptor to heme oxygenase-1 expression and tumorigenesis" (2007) Martín, M.J.;Tanos, T.;García, A.B. (...)Marinissen, M.J. Journal of Biological Chemistry. 282(47):34510-34524

"Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment" (2007) Croci, D.O.;Zacarías Fluck, M.F.;Rico, M.J. (...)Scharovsky, O.G. Cancer Immunology, Immunotherapy. 56(11):1687-1700

"Inhibition of heme oxygenase-1 interferes with the transforming activity of the Kaposi sarcoma herpesvirus-encoded G protein-coupled receptor" (2006) Marinissen, M.J.;Tanos, T.;Bolós, M. (...)Cuadrado, A. Journal of Biological Chemistry. 281(16):11332-11346

"Selection of early-occurring mutations dictates hormone-independent progression in mouse mammary tumor lines" (2006) Gattelli, A.;Zimberlin, M.N.;Meiss, R.P. (...)Kordon, E.C. Journal of Virology. 80(22):11409-11415

"Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: Detection of a non-endothelial function of VEGF in pituitary tumours" (2006) Onofri, C.;Theodoropoulou, M.;Losa, M. (...)Renner, U. Journal of Endocrinology. 191(1):249-261

"Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells" (2005) Proietti, C.;Salatino, M.;Rosemblit, C. (...)Elizalde, P.V. Molecular and Cellular Biology. 25(12):4826-4840

"Involvement of the gp130 cytokine transducer in MtT/S pituitary somatotroph tumour development in an autocrine-paracrine model" (2004) Graciarena, M.;Carbia-Nagashima, A.;Onofri, C. (...)Arzt, E. European Journal of Endocrinology. 151(5):595-604

"Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk" (2003) Páez-Pereda, M.;Giacomini, D.;Refojo, D. (...)Arzt, E. Proceedings of the National Academy of Sciences of the United States of America. 100(3):1034-1039

"Inflammatory changes after cryosurgery-induced necrosis in human melanoma xenografted in nude mice" (2001) Gazzaniga, S.;Bravo, A.;Goldszmid, S.R. (...)Wainstok, R. Journal of Investigative Dermatology. 116(5):664-671

"Sexual dimorphism in diethylstilbestrol-induced prolactin pituitary tumors in F344 rats" (2000) Piroli, G.G.;Torres, A.;Pietranera, L. (...)De Nicola, A.F. Neuroendocrinology. 72(2):80-90

"Angiotensin II-induced Ca2+ mobilization and prolactin release in normal and hyperplastic pituitary cells" (1998) Díaz-Torga, G.;Iglesias, A.G.;Achával-Zaia, R. (...)Becú-Villalobos, D. American Journal of Physiology - Endocrinology and Metabolism. 274(3 37-3):E534-E540

"Microfluorometry and image analysis of peritoneal mast cells reveal differences in the morphology and content of sulfated polyanions between normal and tumor-bearing mice" (1997) Bertolesi, G.E.; Stockert, J.C.; De Cidre, L.L. International Journal of Oncology. 11(6):1221-1225

"Atypical association of H1 and H2 histamine receptors with signal transduction pathways during multistage mouse skin carcinogenesis" (1997) Fitzsimons, C.;Molinari, B.;Duran, H. (...)Rivera, E. Inflammation Research. 46(8):292-298

"Prazosin and stress effect on tumoral growth of 7,12-dimethylbenz[A]anthracene-induced rat mammary tumors" (1996) Wendel, V.;Maris Vazquez, S.;Durante, P.C. (...)Luthy, I.A. Acta Physiologica Pharmacologica et Therapeutica Latinoamericana. 46(4):277-285

"Isolation and partial purification of mitochondrial and cytosolic rhodanese from liver of normal and p-dimethylaminoazobenzene treated mice" (1995) Vazquez, E.;Polo, C.;Stedile, G. (...)Batlle, A. International Journal of Biochemistry and Cell Biology. 27(5):523-529

"Effect of a gonadotropin releasing hormone analog on an experimental ovarian tumor: Direct and indirect actions" (1995) Lux-Lantos, V.A.R.; Thyssen, S.M.; Chamson, A.; Libertun, C. Life Sciences. 57(3):291-300

"Antitumor and cytotoxic screen of 5,6,7-trisubstituted flavones from Gomphrena martiana" (1994) Pomilio, A.B.; Rutty Solá, G.A.; Mayer, A.M.S.; Rumi, L.S. Journal of Ethnopharmacology. 44(1):25-33